transmission 268 electron microscope (Hitachi Ltd)
Hitachi Ltd is a verified supplier 
Hitachi Ltd manufactures this product 
99
Structured Review
Hitachi Ltd
transmission 268 electron microscope
Transmission 268 Electron Microscope, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 48653 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transmission+268+electron+microscope/HT7800/pm41621574-113-85-90
Average 99 stars, based on 48653 article reviews
Transmission 268 Electron Microscope, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 48653 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transmission+268+electron+microscope/HT7800/pm41621574-113-85-90
Average 99 stars, based on 48653 article reviews
transmission 268 electron microscope - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Control:Article Title: DPhA-EtOBz-TSC Targets Cystathionine γ-Lyase (CSE) to Trigger Ferroptosis and Inhibit Colorectal Cancer Growth In Vitro and In Vivo. Article Snippet: 34 Colorectal cancer (CRC) remains one of the most prevalent malignancies globally, 35 with limited therapeutic options for advanced-stage patients due to acquired drug 36 resistance and systemic toxicity.. Ferroptosis, an iron-dependent form of regulated 37 cell death driven by lipid peroxidation, has emerged as a promising therapeutic 38 target for CRC, while cystathionine γ-lyase (CSE)—a key enzyme in hydrogen sulfide 39 (H2S) biosynthesis—plays a critical role in maintaining redox homeostasis and 40 suppressing ferroptosis in cancer cells.. Here, we synthesized a novel small-molecule 41 compound, DPhA-EtOBz-TSC, and systematically evaluated its anti-CRC efficacy and 42 underlying molecular mechanism. Staining:Article Title: DPhA-EtOBz-TSC Targets Cystathionine γ-Lyase (CSE) to Trigger Ferroptosis and Inhibit Colorectal Cancer Growth In Vitro and In Vivo. Article Snippet: 34 Colorectal cancer (CRC) remains one of the most prevalent malignancies globally, 35 with limited therapeutic options for advanced-stage patients due to acquired drug 36 resistance and systemic toxicity.. Ferroptosis, an iron-dependent form of regulated 37 cell death driven by lipid peroxidation, has emerged as a promising therapeutic 38 target for CRC, while cystathionine γ-lyase (CSE)—a key enzyme in hydrogen sulfide 39 (H2S) biosynthesis—plays a critical role in maintaining redox homeostasis and 40 suppressing ferroptosis in cancer cells.. Here, we synthesized a novel small-molecule 41 compound, DPhA-EtOBz-TSC, and systematically evaluated its anti-CRC efficacy and 42 underlying molecular mechanism. Transmission Assay:Article Title: DPhA-EtOBz-TSC Targets Cystathionine γ-Lyase (CSE) to Trigger Ferroptosis and Inhibit Colorectal Cancer Growth In Vitro and In Vivo. Article Snippet: 34 Colorectal cancer (CRC) remains one of the most prevalent malignancies globally, 35 with limited therapeutic options for advanced-stage patients due to acquired drug 36 resistance and systemic toxicity.. Ferroptosis, an iron-dependent form of regulated 37 cell death driven by lipid peroxidation, has emerged as a promising therapeutic 38 target for CRC, while cystathionine γ-lyase (CSE)—a key enzyme in hydrogen sulfide 39 (H2S) biosynthesis—plays a critical role in maintaining redox homeostasis and 40 suppressing ferroptosis in cancer cells.. Here, we synthesized a novel small-molecule 41 compound, DPhA-EtOBz-TSC, and systematically evaluated its anti-CRC efficacy and 42 underlying molecular mechanism. Microscopy:Article Title: DPhA-EtOBz-TSC Targets Cystathionine γ-Lyase (CSE) to Trigger Ferroptosis and Inhibit Colorectal Cancer Growth In Vitro and In Vivo. Article Snippet: 34 Colorectal cancer (CRC) remains one of the most prevalent malignancies globally, 35 with limited therapeutic options for advanced-stage patients due to acquired drug 36 resistance and systemic toxicity.. Ferroptosis, an iron-dependent form of regulated 37 cell death driven by lipid peroxidation, has emerged as a promising therapeutic 38 target for CRC, while cystathionine γ-lyase (CSE)—a key enzyme in hydrogen sulfide 39 (H2S) biosynthesis—plays a critical role in maintaining redox homeostasis and 40 suppressing ferroptosis in cancer cells.. Here, we synthesized a novel small-molecule 41 compound, DPhA-EtOBz-TSC, and systematically evaluated its anti-CRC efficacy and 42 underlying molecular mechanism. |